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Chronic Ischemic Heart Disease: From Concept to Fact
SUZANNE B. KNOEBEL. MD, FACC
Indianapolis. Indiana
The development and refinement of techniques relating
the determinants of increased myocardial oxygen de-
mand to primary or secondary manifestations of inad-
equate myocardial blood flow made possible certain ma-
jor advances in the management of chronic ischemic
heart disease over the past 25 years. These include ob-
jective and quantitative evaluation of the anatomic basis
and the functional consequences of ischemic heart dis-
ease, risk stratification for patient subgroups and doc-
umentation of the effects of therapy. In addition, studies
in which ischemic manifestations were shown to be dis-
sociated from increased myocardial oxygen demand have
redirected attention to the supply component of the sup-
ply to demand balance for myocardial oxygenation.
Diagnostic techniques, management schemata and
therapeutic evaluation methods for the electrophysio-
logic alterations of ischemic heart disease have matured
more slowly than those for the ischemic manifestations.
While the pathophysiologic concepts underlying knowl-
edge of the ischemic manifestations of coronary artery
disease were formulated 25 years ago, in the case of
arrhythmias, new concepts needed to be developed to
"Laboratory methods as applied to the study of climcal medicine
have come to stay: .... We have been too content in the past
with opinion. In the future we shall rest our case upon fact."
Sir Thomas Lewis. 1'J/5 (I)
This quotation from Sir Thomas Lewis has particular rel-
evance to the progress and refinements in the management
of ischemic heart disease that have occurred over the past
25 years. The application of laboratory methods to the study
of patients with angina and other manifestations of coronary
artery disease provided the objective bases for refinements
of old knowledge and clinical perceptions. replacement of
ideas with fact (2) and advances in prognostic ability that
are vital to clinical decision making (3). Few disease states
provide such a clear example of the laboratory to the bedside
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provide the direction for technologic and therapeutic
advances. Although the patients at risk for serious ar-
rhythmias and sudden cardiac events are known to be
those with severe coronary artery disease, impaired left
ventricular function and preexisting electrical instability
as manifested by frequent and complex ventricular ar-
rhythmias, the sensitivity and specificity for any single
factor as a predictor of risk remain to be established.
Similarly, methods to predict efficacyof therapy are still
under development. Progress will accelerate when spe-
cificfactors that predict risk are identified and the meth-
ods for measuring those factors are developed and ap-
plied to the patient in an organized and systematic manner.
The thesis underlying this broad conceptional review
is that the fostering of the full-time clinical investigator
that occurred during the 1960s and the first half of the
1970s and the consequent systematic development and
application of quantitative methods to the study of dis-
ease in human beings were major forces for the re-
markable progress that has been made in the manage-
ment of all aspects of cardiovascular disease.
and back to the laboratory paradigm for clinical progress
and the contribution of clinical investigation to advances in
patient care. Coronary cineangiography. in addition to mak-
ing it possible to delineate anatomic coronary artery disease
in the living human being. brought patients to the laboratory
where the hemodynamic. metabolic and flow concomitants
of coronary disease could be assessed (I). Methods to mea-
sure myocardial blood flow (4) and image the distribution
of myocardial perfusion both at rest and after interventions
to increase or decrease myocardial oxygen demand (5-8)
provided confirmation of the long-held tenet that angina was
the result of an insufficient blood flow relative to demand
(1.9). and demonstrated that there was a relation between
severity of coronary occlusive disease and myocardial blood
flow reserve as proposed by Sir Thomas Lewis (10) in 1932.
The techniques necessary to record electrocardiograms dur-
ing exercise and over extended time periods (II) and to
assess noninvasively ventricular function and wall motion
were developed (12.13). The various techniques were re-
fined and applied to the study of the primary and secondary
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manifestations of coronary artery disease during sponta-
neous and induced ischemia so that precipitating factors.
clinical correlates and the efficacy of therapeutic interven-
tions could be objectively assessed and documented. per-
mitting longitudinal patient evaluation and comparative pop-
ulation studies. The result has been greater diagnostic
precision. the formulation of management decisions based
on objective evidence of mechanisms and severity of disease
and the prognostic implications of both.
Certain bodies of knowledge seem to have had pivotal
influence on research and technologic development direc-
tions. Knowledge concerning the clinically signifi cant pre-
dictors of myocardial blood flow, myocardial blood flow
distribution (supply) and myocardial oxygen requirements
(demand) provided the rationale for the development of
techniques to assess myocardial oxygen demand in relation
to primary or secondary manifestations of ischemia. Such
techniques underlie most of the refinements in the nonin-
vasive diagnosis. management decision making and objec-
tive evaluation of therapy in ischemic heart disease. In ad-
dition. observations on deviations from the classic relations
between supply and demand made possible by such tech-
niques provided the impetus for studies on pathophysiologic
mechanisms for the production of ischemia other than sim-
ply increased work of the heart. Relative to the electrophys-
iologic alterations of ischemic heart disease. documentation
of the link between ischemic heart disease and sudden death
and the concept of premonitory arrhythmias developed from
coronary care unit experience were of major importance in
directing studies designed to provide significant information
for the control of sudden cardiac death and disabling chronic
cardiac arrhythmias.
Because of the central roles that knowledge of the factors
controlling the supply to demand equation for myocardial
oxygenation and the concept of risk factors for arrhythmias
have played in providing the rationale and structure for the
present diagnostic and therapeutic approaches to patients
with latent or manifest ischemic heart disease. these areas
will be the focus of this condensed review of progress in
the management of ischemic heart disease over the past 25
years. Although coronary bypass surgery will not be dis-
cussed, it was perhaps of penultimate importance in the
progress that has been made in the management of chronic
ischemic heart disease. The possibility for and success of
surgical intervention resulted in elimination of the thera-
peutic nihilism that was pervasive concerning coronary ar-
tery disease only 25 years ago. It became important to pursue
early detection and accurate assessment of the extent and
severity of disease (including the presence or absence of
coronary artery disease. fixed or dynamic): the jeopardy
index (percent of myocardium in jeopardy from the com-
bination of all lesions): single event hazards such as left
main coronary artery disease: the functional condition of
the left ventricle and the electrophysiologic state of the heart
with particular reference to the predisposition for potentially
lethal arrhythmias. All of these approaches constitute cur-
rent optimal management for patients with ischemic heart
disease (14).
Some Conceptual Bases for Advances in the
Medical Management of Chronic Ischemic
Heart Disease
It has long been held that anginal pain results from an
insufficiency of myocardial blood flow relative to myo-
cardial requirements for oxygen (1.9), but objective evi-
dence in support of this concept and methods to measure
the significant determinants for each were developed prin-
cipally in the last 25 years. Ross ( I) states that the modern
era of clinical investigation in ischemic heart disease began
with Sir Thomas Lewis and studies at his laboratory by
Wayne and LaPlace (15). These investigators demonstrated
a clear relation between heart rate and the precipitation of
angina with exercise. With the administration of atropine
and the consequent increase in heart rate. duration of pain
was increased and exercise tolerance decreased. The con-
clusions from the atropine experiments were that' ' the dim-
inution in the number of efforts and the increase in the
duration of pain under atropine. . . can be attributed to more
rapid action of the heart. which increases its energy ex-
penditure without a concomitant increase in coronary fl ow
(\ 5 ). ..
Many other clinical studies and observations provided
firm clinical associations between increased oxygen demand
and angina. Indeed. the clinical diagnosis of angina was
dependent on precipitation of the typical chest. arm or neck
discomfort by effort. Anything else. in the opinion of many
master clinicians. was not angina.
Despite the clinical certainty that the ultimate metabolic.
electrocardiographic and functional consequences of coro-
nary disease result from an imbalance between blood supply
and oxygen requirements. early methods of measuring cor-
onary blood flow failed to demonstrate inappropriate fl ows
in patients with coronary artery disease when at rest or under
stresses designed to increase myocardial oxygen require-
ments. Rowe et al. (16) suggested that the apparent dis-
crepancy between the failure to demonstrate an impairment
of coronary flow when indirect reflections of ischemia such
as lactate production and electrocardiographic changes in-
dicated inadequate flow. might have a methodologic basis.
Rowe's perception that methodologic variations were re-
sponsible for certain inconsistent results in the study of
coronary blood flow under the heterogeneous fl ow state
imposed by coronary disease (16) was subsequently dem-
onstrated to be quite correct. With the development of the
instrumentation necessary to measure myocardial radioiso-
tope uptake and content noninvasively (\ 7.18). it became
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feasible to study myocardial blood flow responses to inter-
ventions that alter myocardial oxygen demand in human
beings and different flow patterns in patients with and with-
out coronary artery disease began to be demonstrated. One
of the early isotope techniques developed by Bing and Cohen
and their associates (19,20), utilizing rubidium-84 coinci-
dence counting, provided a more quantitative determination
of isotope content in the myocardium than had previously
been possible (21). Our laboratory utilized this technique
(22) to demonstrate that coronary artery disease results in
a decreased coronary flow reserve (23); there was a good
correlation between the severity of coronary artery disease
and the degree of flow impairment (24). The interventions
used in our studies were cardioacceleration by right atrial
pacing (25), isoproterenol (24), isometric exercise (hand-
grip) (26) and cardioacceleration induced by atropine (27).
Klocke et al. (28), using helium as a tracer. showed a
systematic reduction in average left ventricular flow per unit
weight for the left ventricle in patients with coronary artery
disease studies at rest. Other myocardial flow and perfusion
imaging techniques, developed later and more completely
described in several review articles (8,29,30), evolved into
the current methods for assessing regional myocardial per-
fusion combined with interventions to increase myocardial
oxygen demand.
Role of increased myocardial oxygen demand in isch-
emia. Numerous laboratories in the late I960s and through-
out the 1970s used techniques other than myocardial flow
determination to reflect the presence of inadequate flow and
confirmed the relations between increases in myocardial
oxygen demand by diverse stresses and the precipitation of
ischemia. Sowton et al. (31) and others (32.33) utilized
atrial pacing to test angina threshold. Parker et al. (34)
demonstrated that tachycardia induced by atrial pacing re-
sulted in lactate production in association with ischemia.
Neill et al. (35,36) reached similar conclusions. Robinson
(37) demonstrated that, in a given patient. anginal pain
always started with a combination of hemodynamic con-
ditions that were remarkably constant for each attack. in
particular the product of heart rate and blood pressure. These
two factors were subsequently demonstrated to be of prime
importance as determinants of the threshold for flow reserve
(38). The constancy of the rate-pressure product as a clinical
determinant of myocardial blood flow reserve formed the
basis for using repetitive exercise testing to assess progres-
sion of disease or the efficacy of drug or surgical therapy
(39). Indeed, to this date, the demonstration of alterations
in angina threshold, exercise tolerance or objective mea-
surements of the secondary manifestations of ischemia at
specific levels of the rate-pressure product remains the clin-
ical indicator of efficacy of drug therapy and the marker for
the mechanism of drug action. Evidence for ischemia not
associated with increased cardiac work as reflected by the
rate-pressure product suggests other causes for an imbalance
in oxygen supply and demand.
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Other observations on drug action in the relief of angina
were in conformity with the concept that increased myo-
cardial oxygen demand was the prime factor in precipitation
of angina. Brunton (40) had stated as early as 1867 that
nitrates of amyl were effective because of decreased cardiac
work. MacAlpin et al. (41) confirmed that the increase in
angina threshold reflecting a beneficial effect of nitrogly-
cerin could be related to a reduction in the heart rate and
blood pressure index. Frick et al. (42) also demonstrated
that nitroglycerin prevented attainment of the tension-time
index (43) that would be achieved without nitroglycerin.
The data coming from the many laboratories were so
remarkable for their consistency in describing the qualitative
relations between stresses that increased oxygen demand
and manifestations of ischemia that it is not surprising that
the result was almost total emphasis, clinically. on thera-
peutic measures to correct the imbalance between oxygen
supply and demand by reducing myocardial oxygen require-
ments. It became a well established concept that relief from
angina pectoris was not obtained by increasing coronary
blood flow, as flow was "fixed," but rather through re-
duction of left ventricular work to a level that could be
supported by the diseased circulation. As a result, significant
modifications occurred in the pharmacologic approach to
coronary artery disease that had been dominated for a con-
siderable period of time by the search for coronary vaso-
dilators of greater potency and longer duration (44). The
concept that coronary vasodilation was the exclusive mech-
anism for the efficacy of drug therapy for ischemic heart
disease gradually became obsolete. Charlier (45) stated that
drugs that were truly effective in the patient with angina
probably did not act by coronary vasodilation or that this
mechanism was of secondary importance.
Refinements in the Supply and
Demand Concepts
Stimulated by I) controversies over disparate results from
blood flow studies and the need to understand differences
between "total flow," "nutritional flow," "flow per unit
mass" and other expressions for myocardial perfusion (46),
2) animal studies on the differing effects of various antian-
ginal medications on myocardial blood flow, and 3) the
development of techniques, particularly microsphere tech-
niques, to measure regional myocardial blood flow in ani-
mals, studies on regional flow distribution during the pro-
duction and amelioration of ischemia began to dominate the
literature. Significant advances in the clinical understanding
of the pathophysiology of ischemic heart disease and the
pharmacology of antianginal drugs occurred. It was rec-
ognized that understanding of the global coronary circula-
tion did not supply the information required to understand
all of the clinical manifestations of coronary disease (44).
The emphasis shifted to the microcirculation. Studies rel-
ative to the regulation of regional myocardial perfusion are
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numerous. The key references co mpiled by Hoffman (47)
are useful for those interested in a more deta iled review.
More recent information on the relation between regional
oxygen supply-demand balance , regional flow measure-
ments and resistances is included in the article by Klocke
in this issue of the Journal of the American College of
Cardiology (48). Stud ies considered to have part icular rel-
evance from a conceptual point of view to the clinical de-
velopments of the past few years will be reviewed briefly
here .
Mechanism of action of antianginal agents. In 1966,
McGre gor and Fam (49). on the basis of their pioneering
work on drugs and intramyocardial resistances (50), em-
phasized that in the search for better antianginal agents, the
focus should be placed on those drugs that limit their effect
to large conductance arterial vessels or collateral vessels,
rather than resistance vessels; and drugs that impair auto-
regulatory function should be avoided because such an effect
might actually reduce the amount of blood available to per-
fuse areas of myocardium dependent on collateral channels.
They considered the effectiveness of nitrate preparations in
relieving angina as largely attributable to their different ial
effect on large versus resistance vesse ls in addition to pos-
sible effects through reduction in myocardial oxygen re-
quirements. Winbu ry et al. (5 1) also stressed that favorable
changes in the nutritional circulation should guide the quest
for antianginal substances. They noted that increases in total
blood flow to a region did not necessarily indicate that
nutrient blood flow had increased . These investigators (52,53)
demonstrated that nitroglycerin and beta-receptor blockade
could increase regional nutr ient now to an ischemic region
without altering "total" flow. Data from human studies in
our laboratories (54) indicated that nitroglycerin, in addition
to reducing cardiac work and thereby improving the ratio
betwe en nutritional circulation and oxygen requirements,
also results in probable redi stributi on of nutrient blood flow.
Likewise. animal studies utilizin g microsphere techniqu es
were in accord with flow redi stribution as a mechani sm of
action of antianginal agents (55,56). Investigation concern-
ing the mechani sm of action of nitroglycerin is continuing
and the focus has recently returned to effec ts on the coronary
vasculature (57).
Concept of "coronary steal. " Among concepts stim-
ulated by the work of Fam and McGregor (50). the concept
of " coronary steal" was particularl y useful becau se it in-
spired further research and interest in the problem of myo-
cardial flow distribution (58) . Through an understanding of
the mechani sm whereby coronary vasodilator drugs may.
on occasion. prec ipitate angina while simultaneously in-
creasing total coronary flow and the oxyge n content of cor-
onary venous blood , the control of regional flow was better
understood also . Rowe (58) discussed the possibility that
vasodilator s could be potenti ally detrimental through dila-
tion of normal vessels and the consequent reduction in the
pressure on which the diseased vessels were dependent for
perfusion . It was postulated that resistance vessels in the
myocardium usuall y restr ict flow through nonischemic myo-
cardia l segments , and thus maintain the pressure balance
required to supply the myocardium distal to coronary artery
constricti ons. Howe ver, if the normal arterioles are dilated
by increased oxygen demand or drugs, the pressure in the
larger epicardial "normal" arteries is decreased and blood
is "stolen" from potenti ally ischemic areas as blood flows
along the path of least resistance . Subsequent studies on the
effects of pacing and nitroglycer in on myocardial blood flow
in normal human subjects and patients with coronary disease
were best explained by the concept of " coronary steal," a
reversal of which occurred through a reduction of the work
of the heart with nitroglycerin (59) . There were also studies
in experimental animals utilizing methods to measure re-
gional flows. These studies confirmed the presence of the
coronary steal phenomenon and presented in detail the con-
ditions under which steal was most likely to occur (60-62 ).
In addition. there was renewed interest in the presence and
significance of coronary collateral function and the " pro-
tect ive" ability of collateral vesse ls (63-65). as well as of
the dynamics of flow in the complicated state of a diseased .
mult iobstruct ed coro nary artery tree (66) . It is interesting
that the concept of coronary steal may soon be revived with
the reint roduction of agents with coro nary vasodilating prop-
erties (67) .
Diastolic and systolic time and pressure indexes to
predict distribution of myocardial flow. Increased knowl-
edge of the determinants of flow in the microcirculation
resulted in refinements in the supply/demand ratio formu-
lat ion for predicting the response of the coronary circulation
to various interventions and therapies. A mathematical model
of the coronary circulation developed by Gordon (68) and
experimental and clinical counterparts fashioned by Brazier
and Buckberg and associates (69. 70) emphasized diastolic
events pertinent to subendocardial perfusion and provided
information significant for the clinica l manipulation of flow
distribution . The distribution of myocardial blood flow be-
tween epicardium and endocardium in the experimental an-
imal was shown to be predictable from the ratio of the area
between the aortic and left ventricular pressure curves in
diastole (OPTI) and the myocardial oxygen demand as re-
flected by the tension-time index (TTl) (7 1). The OPTl/TTI
formulation as a predi ctor of the response of the coronary
circulation to various stimuli affecting either the supply or
demand side of the ratio and the components of each has
been studied in human beings (72). The data demonstrated
that all of the stresses studied resulted in a differential re-
sponse in myocardial blood flow in patients with varying
degrees of severity of coronary artery disease , and that the
differential response could be predicted by the effect of the
intervention on the OPTI /TTI ratio. Other studies also have
emph asized the clinical implications inherent in specific
components of the diastolic and systolic time indexes (73) .
Subendocardial perfusion and perfusion distal to an obstruc-
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tion are nearly all diastolic. As such, they are related not
only to diastolic perfusion pressure and microcirculatory
tone but also to diastolic time (73,74), providing support
for the clinical emphasis on heart rate as a prime consid-
eration in antianginal therapy.
An example of clinically important information stimu-
lated by the mathematical modeling ofGordon (68) was the
emphasis on left ventricular pressure as afactor influencing
the supply/demand ratio. It was predicted from the model
that increased left ventricular end-diastolic pressure would
tend to precipitate angina or to reduce angina threshold and,
similarly, that procedures that reduced this pressure would
tend to have the opposite effect. These predictions were
confirmed clinically. In patients with coronary artery disease
it was shown that a rapid transfusion causing significant
elevation of left ventricular end-diastolic pressure precipi-
tated angina (75). The prediction that reduction of left ven-
tricular end-diastolic pressure would increase the angina
threshold was also confirmed clinically by Parker et al. (76).
It is now common knowledge that diuretic drugs and, on
occasion, digitalis may be antiischemic interventions (77).
Role of coronary vascular geometry and tone. The
multiplicity of the physiologic consequences of coronary
artery disease was more readily appreciated as knowledge
concerning the specific factors that controlled regional flow
distribution accumulated. The regional effects of coronary
obstructive disease were increasingly understood, and the
results of alterations in specific resistances better appreciated
(48,78,79). It became important to quantitate the hemo-
dynamic severity of coronary lesions, and it was demon-
strated that the geometric characteristics of the lesions-
length, divergence angles, eccentricity and post-stenotic di-
lation-were of significance to coronary flow dynamics
(48,80). Interest in the effects of the cardiac sympathetic
nerves and autonomic mediators on the coronary circulation
was also rekindled. The direct actions of adrenergic agents
on the coronary vasculature were and continue to be difficult
to separate from the secondary effects induced by almost
simultaneous changes in transmural pressure and myocardial
metabolism (81-83). However. there is increasing evidence
in animals and human beings that dynamic changes in cor-
onary "tone" and vascular resistances can influence normal
vessels as well as those already compromised by athero-
sclerotic lesions (84-88). Vasoactive substances of all types
are of increasing interest (89,90). In essence, a transition
is occurring away from the concept that, in the presence of
coronary artery disease, resistances are fixed when the va-
sodilator reserve capacity at the arteriolar level is reached.
toward the concept that coronary resistances may be variable
due to changes in coronary "tone," the mechanisms for
which may be quite diverse (88).
From the clinical point of view. interest in coronary
vascular tone was revitalized by the work of Maseri and
associates (91), who demonstrated that spasm may be a
mechanism for the induction of ischemia unrelated to altered
determinants of myocardial oxygen demand. Although the
concept of dynamic obstruction is not new (Osler [92J de-
fined angina pectoris as "a disease characterized by par-
oxysmal attacks of pain . . . associated with changes in
the arterial walls. organic or functional," and implied that
myocardial ischemia can be associated with fixed coronary
obstruction or dynamic narrowing), conceptually the dem-
onstration of ischemia dissociated from metabolic demand
has again stimulated clinical investigation into the control
of coronary inflow. We may have come full circle from
the concept that coronary dilation was the prime focus for
the control of ischemia, to control of the determinants of
oxygen demand. to coronary dilation once again. The de-
velopments of the past few years have refocused attention
on the supply side of the oxygen supply to demand equation.
Investigation of the therapeutic role and mechanisms of
action of agents with vasodilating properties of the calcium
entry blocking type for chronic and acute ischemic mani-
festations are burgeoning. The return of the coronary va-
sodilator approach to antiischemic therapy may evoke the
return of coronary steal considerations (67) and concerns
over drugs that although reducing myocardial oxygen de-
mand may also result in more pronounced coronary artery
vasoconstriction (73). The conceptual return to supply side
control of the coronary circulation will require technologic
advances that will allow study of the coronary vasculature
at the macro- and, perhaps, micro-levels in order to again
make progress by . 'resting our case upon fact (1,48). "
Some Concepts Underlying Advances in the
Management of the Electrophysiologic
Alterations of Ischemic Heart Disease
Although the association between angina pectoris and ex-
trasystoles both at rest and with exertion was known. and
precipitation of arrhythmia by exercise, presumably related
to myocardial ischemia, had been demonstrated in numerous
studies before 1958, the significance of premature ventric-
ular complexes as a risk factor for future cardiac events was
not emphasized clinically. The link between arrhythmias,
coronary artery disease and sudden death was not as wen
established as that for disease of the coronary arteries, car-
diac work and angina. Indeed, it was the establishment of
this link and the mechanisms involved that engaged clinical
investigators for the major portion of the past 25 years.
Chapters in standard textbooks in 1958 either did not men-
tion arrhythmia in the context of ischemic heart disease or
gave it little emphasis. Certainly it was not because sudden
death was unknown. Apparently the affliction was so wide-
spread in the Roman populace of 1706 that Pope Clement
XI directed his personal physician, Giovanni Maria Lancisi,
to make a study of its causes. In 1707 Lancisi published
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Figure I. The prevalence of premature ventricular complexes of all grades
is shown in relation to maximalexercise heart rate for patientswith coronary
artery disease and exercise thallium-20l perfusion studies. If the thallium-
201 perfusion defects were reversible. ischemia was said to be present. If
the perfusion defects were nut reversible. scar was diagnosed.
during 43 months of follow-up study after myocardial
infarction.
In early studies on the contribution of ventricu lar ar-
rhythm ias to sudden death , Chiang et al. (108) reported a
statistically significant increased rate of sudden death in
subjects over age 30 with ventricular extrasystoles. Hinkle
et al. ( 109) by assessing the occurrence of ventricular ex-
trasystoles on 6 hour electrocardiographic recordings reached
similar conclusions. However. subsequent studies by Hinkle
and co-workers ( 110) in a larger population indicated that
premature ventricular complexes in the absence of other
major coronary risk factors were not associated with in-
creased mortality over a 2.5 year follow-up period. As with
resting premature ventricular complexes. exercise-induced
premature ventricular complexes have been shown to be
common in normal populations. not reproducible in normal
subjects and poor predictors of subsequent cardiac events.
Role of grading systems for ventricular arrhyth-
mias. With the recognition that ventricular arrhythmias were
so common in patients with ischemic heart disease as well
as in normal subjects that their mere presence had little
significance, Lown and Wolf (III) proposed a grading sys-
" De Subitaneis Morti ... ,. in which sudden death was
related to diseases of the cardiovascular system (93).
Ventricular arrhythmia and sudden death link. It is
probable that clinical attention was directed to the links
among ischemic heart disease, arrhythmia and sudden death
as the result of several developments. These include tech-
niques for cardiac resuscitation and the consequent reduction
in therapeutic nihilism, an increased awareness of coronary
artery disease as a major health problem, the availability of
instrumentation for recording the electrocardiogram contin-
uously with exercise and over extended time periods and,
most importantly, the experience gained in coronary care
units with premonitory arrhythmias and the precipitation of
ventricular tachycardia or ventricular fibrillation. For what-
ever reasons, "consideration of the electrophysiological state
of the myocardium" (14) as a requirement for optimal clin-
ical care of the patient with chronic ischemic heart disease
has been stressed only in the past few years.
The direct link between an altered electrophvsiologic
state of the myocardium and sudden death has been difficult
to confirm . In the evolution of studies designed to establish
that link, several risk factors that discriminate at the pop-
ulation level have emerged, namely. the extent of coronary
artery disease (94- 97), the presence and extent of left ven-
tricular dysfunction (98.99) and the presence or absence of
evidence for left ventricular electrical " instability" in the
form of rest or exercise electrocardiographic abnormalities
with or without arrhythmia.
Relative to the anatomic substrate fo r sudden death. an
early study (100) in Westchester County. New York. cov-
ering the period from 1949 to 1959, of white men dying
suddenly (within I hour) found that coronary artery disease
was present in 90% of cases and the lesions were diffuse
and involved all main coronary arteries. Subsequent studies
( 101 , 102) utilizing cardiac catheterization or autopsy also
demonstrated that severe multivessel obstructive disease of
the epicardial coronary arteries is present in the majority of
cases. The evidence for the contribution of left ventricular
dysfunction to an increased risk for sudden death is also
convincing. The most compelling evidence has come from
studies of survivors of sudden death (103 -105 ). the majority
of whom have exhibited moderate to marked compromise
of left ventricular function in addition to severe coronary
artery disease.
Electrocardiographic alterations that have been asso-
ciated with an increased risk for sudden death include pro-
longed QT interval and ST-T changes. A study by Haynes
et al. ( 106) demonstrated that the QTc interval was pro-
longed in a significantly greater proportion of survivors of
ventricular fibrillation than of patients withouta similarevent.
Boudoulas et al. (107) demonstrated that prolongation of
the QT interval relative to the duration of the QS2 interval
(interval from the onset of electrical depolarization to the
second heart sound) detected 65 % of patients who died
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tem based on certain characteristics to identify " malignant"
prem ature ventricular compl exes. The characteristics were
increased frequency of premature ventricular complexes,
multiformity . repetitive compl exes (couplets or salvos) and
early cycle premature ventricular complexes. Since that time.
the grading system has been used extensively to study the
associations between ventricular arrhythmias and sudden
death (1 2). left ventricular dysfunction 01 3-115) , drug
effects (116 ). autonomic influences and repolarization al-
terations ( 106. 117). Although the gradin g system, with re-
finements, has been useful , it is a hierarchical system and
as such does not permit studies relating the frequency or
complexity of premature ventricular complexes to other clin-
ical con comitants such as left ventri cular function or mor-
tality rate (118). This is a limitation. because if frequency
of arrhythmia or arrhythmia by type is to be convincingly
dem onstrated to be predictive of risk. other factors also
asso cia ted with risk and specific arrhythmia frequency need
to be considered (19). For example . the frequenc y of ex-
erci se-related ventricular arrh ythmi as in patient s with cor-
onary artery disease has been show n to increase with age ,
sex . heart rate achie ved, severity of coronary artery disease.
previous myocardial infarction. contractile abnormalities at
rest and exercise-induced ST segment depression (120-124).
It has been suggested that because all of these factors
increase the likelihood of impaired ventricular function,
ventricular dysfunction may be the common denominator
(20). However, studies to deline ate specific transient or
permanent hemodynamic or other alterations that may act
as independent factors influen cing the prevalence of ar-
rhythmia are few . In a study we performed to assess the
relation between ventricular arrhythmias and reversible
(ischemia) and fixed (scar) per fusion defects as detected by
thallium-20 I imaging, the importance of heart rate "match-
ing " was made clear (Fig. I). If the patient group without
ischemia or scar had consisted prim arily of patients with a
heart rate of approximately 135 or ISO beats /min, whereas
the other groups had come from the 115 beats/min range ,
the only significant difference would have been between the
patients with ischemia plus scar and those with no defect.
The contribution of ischemia or scar alone would not have
been apparent. With heart rate grouping, howe ver. ischemia
emerged as a significant independent factor for arrhythmi a
frequency . It is possible that some of the discrepancies be-
tween studies comparing ventricular ectopic activity and
other variables may be due to this dependency of frequency
of arrhythmia on heart rate and the failure to assess the
effect of heart rate on the conclusions.
Arrhythmias as independent predictors of cardiac
events. Through the util ization of multi variate analyses.
studies are beginning to confirm the independent contri-
bution of arrhythmias to subsequent cardiac event s. For
example. in association with manife st heart disease . ar-
rhythmi as induced by exercise have been demonstrated to
have predi ctive power. Uda ll and Ellestad (125 ) evaluated
the predictive impli cations of prem ature ventricular com-
plexes associ ated with exercise stress testin g in 1.327 pa-
tient s. The annual incidence of new coro nary event s (in-
cluding sudden death ) during a 5 yea r follow-up per iod was
1.7% in patients without premature ventricular complexes
or ischem ic ST changes. 6 .4% in patients with prem ature
ventricular complexes alone, 9 .5% in patient s with ischemia
alone and 11.4 % in pat ients with premature ventricular com-
plexe s and ischemic ST changes . Furthermore. also utilizing
multiv ariate analyses. other studies have demonstrated an
independent contribution of ventricular arrhythmias induced
by exercise (126) as well as those occurring during ambu-
latory monitoring (127) to the risk for mortality in patients
with heart disease.
Although data of this type are now convincing for the
general associations between arrhythmias at rest or with
exercise and sudden death , the ir applicability to the man-
agement of the individual patient is less direct. A recent
study by Weaver et at. (128) demonstrated that although a
strong statistical association existed between ectopic com-
plexes documented durin g ambulatory monitoring and sub-
sequent cardiac arre st , ambulatory arrhythmias are of little
predictive value for the individual patient becau se they are
neither highly sensitive nor specific.
Myocardial factors contributive to arrhythmogene-
sis. It has been suggested that further characterization of
arrhythmias by type is unl ikely to enhance the abilit y to
predict the sudden death syndro me or chronic incapacitating
arrhythmias (128) . Rather , present indications are that ef-
forts should be aimed at clarify ing the electrophysiologic
and myocardial matrix in which complex forms and ven-
tricular tachycardia and fibrillation are initiated, exacerbated
or ameliorated .
Working under the hypothesis that ventricular arrhyth-
mias may well be a dynami c and evolving event . we recently
performed a pilot study to determine whether variations in
cycle length , which might reflect autonomic influence or
result in hysteresis of action potential duration adjustment
and consequent electrical inhom ogen eity ( 129), would pre-
dict the emergence of ventricular tachycardia . The results
( 130) suggest strongly that this is the case and that envi-
ronmental conditioning is a requ irement for arrhythmi a
emergence or exacerbation . In another recent study . Nikolic
et at. (131 ) point out some very significant observation s
relative to the possible dynamic changes predi sposing to
lethal ventricular arrh ythm ias. The y reviewed the clinical
and electroca rdiographic features in 6 instances of sudden
death record ed by Holter monitoring from their patient group
and in 15 additional reported cases . The composite profile
included advanced myocardial disease in all. complex ven-
tricular ectopic activity and R on T initia tion of the terminal
ISCHEMIC HEART DISEASE J AM COl l CARDIOl
1983:1:20- 30
27
rhythm in the absence of a prolonged QT interval. They
noted that variations in cycle length preceded the onset of
ventricular tachycardia or ventricular fibrillation , an obser-
vation in accord with our findings .
In another study (132) of factors predisposing to ven-
tricular fibrillation in 48 consecutive patients who devel-
oped ventricular fibrillation outside the hospital. a signifi-
cant increase in heart rate was recorded immediately before
ventricular fibrillation. The initiating factor was an R on T
extrasys tole in 69% of the patients. The publi shed records
also demonstrated varying cycle lengths before ventricular
fibrillation. Although the time span over which the signif-
icant dynamic changes occur may be too short to be of
predict ive or therapeutic importance for individual patients
with single episodes of ventricular tachycardia or fibrilla-
tion, the knowledge derived from such dynamic studies may
be of significance for the ident ification of critical myocardial
or extracardiac factors relat ing to increased risk.
Electrophysiologic testing. Another approach to iden-
tifying and treating the patient at risk is electrophysio logic
testing (133) . The hypothesis underl ying the various inva-
sive techn iques is that ventricular tachycardia can be induced
only in those patients prone to its spontaneous development.
Proponents conclude that the inducti on of ventricular tachy-
cardia even in an asympt omatic patient identifies that patient
as one who requires antiarrhythmi c therapy (134). It has not
been conclusively demonstrated , however , that electroph ys-
iologic testing has reached the point where it can be used
as an independent marker of patients at risk for sudden
cardiac death. As with spontaneous arrhythmia, inducibility
may be dependent on the myocardial and electrophysiologic
matrix existing at the moment of induction. The specific
factors contributing to inducibility are under intensive study.
Comments
Applications to diagnosis. The past 25 years have seen
the devel opment of a new body of cl inical information and
skills important in the mana gement of patients with ischemic
heart disease . The diagnosis of coronary artery disease was
almost totally depend ent on the clinical history before the
development of techn iques to measure or reflect a decreased
myocardial blood supply relative to demand . Present di-
agnostic eva luation involves a stepwise collection of in-
creasingly specific data, the goa l being to document objec-
tively the presence or absence of fixed or dynamic occlusive
disease and , if present , to quant itate the degree of anatom ic
and functional impa irment. Diagnostic accuracy and quan-
titative capability have become importa nt because therapies
are now avai lable with the potent ial for altering the course
of the disease in certain SUbgro ups of patients (135) and for
ameliorating the symptoms in a much larger group. Fur-
thermore, the choice of therapy is guided by risk predicti ons
based on knowledge of the degree of anatomic disease and
the resultant functional impairment balanced with infor-
mation about the efficacy of any part icular therapy.
Applications to therapy. Because of the increased
knowledge concerning the determ inants of myocardial blood
flow developed largely durin g the last 25 years , medical
therapy for an individu al patient can be tailored to alter the
factors prim arily responsible for the precip itation of the
signs and symptoms of ischem ia in that patient ; and efficacy
of the therapy can be assessed util izing the same techniques
that were applied for the diagnosis and eva luation. If surg ical
therapy is chosen, the choice can be made with the knowl-
edge that, if the patien t has been properly selected and
surgery properly performed , the therapy will increase myo-
cardia l perfusion (136), an achievement not previously doc-
umented for surgical reva scularization techniques that pre-
ceded coronary bypass surgery . Furthermore. the
recomm endation for surg ical therapy can be made with the
knowled ge that the risk of the surgery is minimal if attent ion
is paid to preservation of myocard ium dur ing the procedure
and to the recognition and proper therapy of perioperative
complications. From the state of therapeutic nihilism rela-
tive to ischemic heart disease that many of us rememb er . a
management plan has evo lved based on increa sed knowl-
edge of pathophysiolo gy, drug action and risk prediction.
Most of the important developments have been made pos-
sible by basic and clini cal research. technologic advances .
improved data management systems. increased statistica l
sophistication and the applicatio n of all these to the study
of ischemic heart disease in human beings.
Applications to arrhythmias. The precedin g consider-
ations are applicable to the ischemic manifestation s of ob-
structive and , possibly, dynamic coronary artery disease .
The pathophysiologic aspects of arrhythmogenesis in the
human ventricle are less well characterized and. therefore,
the management schemata for arrhythmias lack the precision
of those for ischemia. Although risk factors for future car-
diac events secondary to arrhythmia are reasonabl y well
establis hed for groups of patients , management of the elec-
trophysiologic consequences of ischemic heart disease in
individual patients is still empirical. The capability for mea-
suring the cri tical electrophysio logic or myocardial factor s
of significance for the precip itation . exacerbation or ame-
lioration of potenti ally lethal arrhythmias in the individu al
patient and the coroll ary, the means to assess therapeut ic
efficacy, are not yet available. It is anticipated. however,
that exciting times are ahead. The times were exc iting dur ing
the evol ution of the "ischemic connection." It may well be
that the clear definition of the ' 'arrhythmia connection" will
place on research , technologic development and the clinical
inves tiga tor an even grea ter demand to convert basic con-
cept to fact relat ive to the patient with disease than was
required for other manifestations of coronary artery disease .
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